WHO ICTRP trial

ACCURACY OF RETINOMAX K- PLUS 3 ( hand held autorefractor) VERSUS CYCLOPLEGIC…

CTRI/2022/09/045186 · Clinical Trials Registry India (CTRI) · Not Recruiting

Key facts

Trial ID CTRI/2022/09/045186
Public title ACCURACY OF RETINOMAX K- PLUS 3 ( hand held autorefractor ) VERSUS CYCLOPLEGIC RETINOSCOPY FOR MEASURING REFRACTIVE ERROR IN CHILDREN.
Scientific title ACCURACY OF RETINOMAX K- PLUS 3 VERSUS CYCLOPLEGIC RETINOSCOPY FOR MEASURING REFRACTIVE ERROR IN CHILDREN.
Primary sponsor DR KRITI NAUSARAN
Registry Clinical Trials Registry India (CTRI)
Recruitment status Not Recruiting
Study type Observational
Countries India
Conditions Health Condition 1: H522- Astigmatism Health Condition 2: H520- Hypermetropia Health Condition 3: H521- Myopia
Interventions Control Intervention1: RETINOMAX K PLUS 3, RETINOSCOPE: RETINOMAX IS HANDHELD AUTOREFRACTOR
Registration date Feb 9, 2022
Target size 70
Secondary IDs NIL
Registry page ctri.nic.in

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations